Filters

anti-G protein alpha Inhibitor 2 (1-355, His-tag) Antibody

anti-G protein alpha Inhibitor 2 (1-355, His-tag) Antibody size: 0,5 mg 1413

Supplier ACR
Price 1413
Size 0,5 mg
Contact us Ask Component cell markers and DNA bp. markers are genetic markerser genes or DNA sequenceswith selection audit
Vial description GNAI2B, GNAI2
Categoryantigen
Raised inlaboratory
Clone1 vial
FormPurified
Reactivitynot determined
Purity>, 90%
Molecular weight42 kDa
Source coli, E
Activityto be determined
Rangebroad
Protein numberP04899
Applicationnot determined
Storage Avoid freeze/thaw cycles, Upon delivery aliquot and store at -20°, C, C for one year, Shipped at 4°
Description Freeze thaw will destroy a percentage in every cycle and should be avoided, Not all receptor antagonist that bind to enzymes are inhibitors, Since blocking an enzyme's activity can kill a pathogen , Tissue, activator, caspase, esterase inhibitors , lipoprotein, many drugs are enzyme inhibitors, papain, pathway, peptidase, protease , proteinase, trypsin, while enzyme substrates bind and are converted to products in the normal catalytic cycle of the enzyme,  , C in a fridge short term in a concentrated dilution, This antibody needs to be stored at + 4°, acrosin, activity, and decreases its , are , bind to enzymes and increase their , enzymatic activity, enzyme activator ligands or agonists , enzyme receptor , imbalance, metabolic , or correct a , or receptor ligands or receptor antagonists that bind to an , proteins 
PropertiesC, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by acr they should be stored frozen at - 24°
Conjugationhistidine
Gene target His-tag), G protein alpha Inhibitor 2 (1-355
Short name His-tag) Antibody, anti-G protein alpha Inhibitor 2 (1-355
Technique antibodies against human proteins, antibodies for, antibody to, Antibody
LabelHis
Alternative name histidine-detection labelled) (Antibody to), antibody to-G protein a suppressor 2 (1-355
Alternative techniqueantibodies

Similar products

Subscribe to our Newsletter